<DOC>
	<DOCNO>NCT00349622</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy ceftriaxone treatment amyotrophic lateral sclerosis ( ALS ) .</brief_summary>
	<brief_title>Clinical Trial Ceftriaxone Subjects With ALS</brief_title>
	<detailed_description>It know nerve cell call motor neuron die brain spinal cord people amyotrophic lateral sclerosis ( ALS ) . However , cause cell death unknown . Researchers think increase level chemical call `` glutamate '' may relate cell death . For reason researcher want study drug decrease glutamate level near nerve . Ceftriaxone—a semi-synthetic , third generation cephalosporin antibiotic—may increase level protein decrease glutamate level near nerve . Studies ceftriaxone laboratory suggest may protect motor neuron injury . Ceftriaxone approve U.S. Food Drug Administration ( FDA ) treat bacterial infection treat ALS . Also , ceftriaxone give people long period time , month year . The goal study evaluate safety effectiveness ceftriaxone treatment ALS , determine safety effectiveness long-term use drug people ALS . A total 600 eligible people ALS enrol multi-center research study . Participants randomly assign receive treatment ceftriaxone ( 2/3 participant ) placebo ( 1/3 participant ) least 12 month . The study consist three stage . The first stage , complete enrollment , look whether ceftriaxone enters cerebrospinal fluid ( fluid surround spinal cord , also call CSF ) amount high enough possible benefit . The second stage , also complete enrollment , look safety side effect study drug take daily least 20 week . The study currently enrol subject third stage , begin Spring 2009 , determine whether study drug prolongs survival slow decline function due ALS .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>Participants people ALS , least 18 year age . Participants must medically able undergo study procedure caregiver individual available help daily study medication administration . Participants live within reasonable distance study site , due frequent study visit . Participants take experimental medication ALS , history sensitivity cephalosporin antibiotic ( Ancef , Keflex , Ceclor , Ceftin , Lorabid , Suprax , Fortaz ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>amyotrophic lateral sclerosis</keyword>
	<keyword>ALS</keyword>
	<keyword>ceftriaxone</keyword>
	<keyword>cephalosporin antibiotic</keyword>
	<keyword>motor neuron</keyword>
</DOC>